Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $17.545, down 0.09% on the day, near its 52-week high of $17.53. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $0.59 surpassing the $0.502 estimate. Technical indicators show a bullish trend, while fundamentals reveal revenue of $14.30B in 2025 but a net loss of $3.51B. The company secured FDA approval for Gwyn Lo™ contraceptive patch in July 2026, a positive development for its women's health portfolio.
The outlook is mixed: analyst consensus is a 'Hold' with a $20.00 price target, implying 14% upside, but profitability challenges and potential generic drug tariffs pose risks. Cash flow improved to $612M net in 2025, and debt-to-asset ratio declined to 33.82% in 2024, supporting stability. Investors should weigh earnings momentum against margin pressures and regulatory uncertainties.
Read full analysis

Key Stats

  • Market Cap
    $20.68B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $8.75
  • Typical Hold Time
    -
  • Enterprise Value
    $32.89B
  • Div Yield
    2.73%
  • Trading Activity
    -
$17.54
52W Low: $8.75
06 Aug 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.75 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

New Deserve to Win Podcast episode features telecom CEOs discussing industry shakeup and legal updates.

The latest episode of Troutman Amin, LLP's Deserve to Win Podcast features interviews with CEOs from Contact Center Compliance, PureCaller ID, and Sonera, discussing the merger of CCC and PCID into Sonera and its impact on telecom industry consolidat...

Market News
1 hour ago
Not Specified
Neutral
pluang ai news

Pepeto presale nears sellout amid record holder growth and Solana price rebound.

Pepeto's crypto presale is rapidly selling out, raising over $10.398 million despite a challenging market, signaling strong investor interest. This surge coincides with Solana's price recovery to $81 and optimistic forecasts of $500 in 2026, highligh...

Market News
2 hours ago
Not Specified
Bullish
news icon
pluang ai news

Elon Musk’s robot could generate more revenue than Amazon’s $600B yearly sales, says James Altucher.

James Altucher projects that Elon Musk's humanoid robot, dubbed "A.R.M.," could surpass Amazon's $600 billion annual revenue by producing up to 10 million units yearly. Priced between $20,000 and $30,000 each, initial production of 1 million robots c...

Market News
2 hours ago
James Altucher
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $20.68B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $8.75
  • Typical Hold Time
    -
  • Enterprise Value
    $32.89B
  • Div Yield
    2.73%
  • Trading Activity
    -
$17.54
52W Low: $8.75
06 Aug 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.75 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!